ENB vs. NVS

Last updated Apr 2, 2026

Compare and contrast key facts about Enbridge Inc. (ENB) and Novartis AG (NVS).

Performance

ENB vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enbridge Inc. (ENB) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

ENB vs. NVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ENB Enbridge Inc.	13.67%	19.51%	26.35%	-1.13%	6.46%	30.83%	-13.60%	36.05%	-15.53%	-2.73%
NVS Novartis AG	15.91%	46.95%	0.02%	16.14%	8.06%	-3.65%	3.34%	13.92%	5.95%	19.42%

Fundamentals

EPS ENB : $8.09 NVS : $7.20
PE Ratio ENB : 6.63 NVS : 21.55
PEG Ratio ENB : 0.31 NVS : 1.46
PS Ratio ENB : 1.20 NVS : 5.37
Total Revenue (TTM) ENB : $65.19B NVS : $56.15B
Gross Profit (TTM) ENB : $0.00 NVS : $41.12B
EBITDA (TTM) ENB : $10.66B NVS : $22.99B

Returns By Period

In the year-to-date period, ENB achieves a 13.67% return, which is significantly lower than NVS's 15.91% return. Over the past 10 years, ENB has underperformed NVS with an annualized return of 10.07%, while NVS has yielded a comparatively higher 12.09% annualized return.

ENB

• 1D: -0.91%
• 1M: -0.57%
• YTD: 13.67%
• 6M: 11.18%
• 1Y: 27.42%
• 3Y*: 19.61%
• 5Y*: 15.05%
• 10Y*: 10.07%

NVS

• 1D: 1.53%
• 1M: -4.24%
• YTD: 15.91%
• 6M: 21.32%
• 1Y: 45.79%
• 3Y*: 23.19%
• 5Y*: 16.79%
• 10Y*: 12.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ENB vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENB

ENB Risk / Return Rank: 83
ENB Sharpe Ratio Rank: 85
ENB Sortino Ratio Rank: 80
ENB Omega Ratio Rank: 79
ENB Calmar Ratio Rank: 85
ENB Martin Ratio Rank: 84

NVS

NVS Risk / Return Rank: 90
NVS Sharpe Ratio Rank: 91
NVS Sortino Ratio Rank: 89
NVS Omega Ratio Rank: 87
NVS Calmar Ratio Rank: 90
NVS Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENB vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enbridge Inc. (ENB) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ENB	NVS	Difference
Sharpe ratio Return per unit of total volatility	1.61	2.13	-0.52
Sortino ratio Return per unit of downside risk	2.17	2.74	-0.57
Omega ratio Gain probability vs. loss probability	1.29	1.36	-0.08
Calmar ratio Return relative to maximum drawdown	3.00	4.03	-1.02
Martin ratio Return relative to average drawdown	7.45	11.81	-4.36
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ENB vs. NVS - Sharpe Ratio Comparison

The current ENB Sharpe Ratio is 1.61, which is comparable to the NVS Sharpe Ratio of 2.13. The chart below compares the historical Sharpe Ratios of ENB and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ENB	NVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.61	2.13	-0.52
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.82	0.91	-0.09
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.41	0.62	-0.21
Sharpe Ratio (All Time) Calculated using the full available price history	0.52	0.43	+0.09

Correlation

The correlation between ENB and NVS is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ENB vs. NVS - Dividend Comparison

ENB's dividend yield for the trailing twelve months is around 5.12%, more than NVS's 3.08% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ENB Enbridge Inc.	5.12%	5.66%	6.28%	7.31%	6.80%	6.85%	7.55%	5.58%	6.68%	4.71%	4.13%	4.71%
NVS Novartis AG	3.08%	2.90%	3.84%	3.44%	3.70%	3.86%	3.22%	3.03%	3.47%	3.24%	3.73%	3.10%

Drawdowns

ENB vs. NVS - Drawdown Comparison

The maximum ENB drawdown since its inception was -46.35%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for ENB and NVS.

Drawdown Indicators

	ENB	NVS	Difference
Max Drawdown Largest peak-to-trough decline	-46.35%	-42.10%	-4.25%
Max Drawdown (1Y) Largest decline over 1 year	-9.37%	-10.76%	+1.39%
Max Drawdown (5Y) Largest decline over 5 years	-28.32%	-20.42%	-7.90%
Max Drawdown (10Y) Largest decline over 10 years	-44.07%	-26.03%	-18.04%
Current Drawdown Current decline from peak	-1.70%	-5.23%	+3.53%
Average Drawdown Average peak-to-trough decline	-10.87%	-10.94%	+0.07%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.78%	3.67%	+0.11%

Volatility

ENB vs. NVS - Volatility Comparison

The current volatility for Enbridge Inc. (ENB) is 3.55%, while Novartis AG (NVS) has a volatility of 6.44%. This indicates that ENB experiences smaller price fluctuations and is considered to be less risky than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ENB	NVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.55%	6.44%	-2.89%
Volatility (6M) Calculated over the trailing 6-month period	11.65%	14.50%	-2.85%
Volatility (1Y) Calculated over the trailing 1-year period	17.11%	21.68%	-4.57%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.49%	18.52%	-0.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.41%	19.55%	+4.86%

Financials